S&P 500   3,390.76 (+0.61%)
DOW   29,382.10 (+0.51%)
QQQ   237.18 (+1.04%)
FB   217.85 (+0.02%)
MSFT   187.34 (+0.06%)
GOOGL   1,529.14 (+0.64%)
AMZN   2,179.85 (+1.12%)
NVDA   312.51 (+5.37%)
MU   59.62 (+3.24%)
GE   12.76 (+0.08%)
AMD   59.09 (+3.87%)
ACB   1.70 (+3.66%)
F   8.01 (-0.62%)
NFLX   388.29 (+0.13%)
BAC   34.79 (+1.52%)
DIS   141.17 (+1.46%)
GILD   67.14 (+0.18%)
S&P 500   3,390.76 (+0.61%)
DOW   29,382.10 (+0.51%)
QQQ   237.18 (+1.04%)
FB   217.85 (+0.02%)
MSFT   187.34 (+0.06%)
GOOGL   1,529.14 (+0.64%)
AMZN   2,179.85 (+1.12%)
NVDA   312.51 (+5.37%)
MU   59.62 (+3.24%)
GE   12.76 (+0.08%)
AMD   59.09 (+3.87%)
ACB   1.70 (+3.66%)
F   8.01 (-0.62%)
NFLX   388.29 (+0.13%)
BAC   34.79 (+1.52%)
DIS   141.17 (+1.46%)
GILD   67.14 (+0.18%)
S&P 500   3,390.76 (+0.61%)
DOW   29,382.10 (+0.51%)
QQQ   237.18 (+1.04%)
FB   217.85 (+0.02%)
MSFT   187.34 (+0.06%)
GOOGL   1,529.14 (+0.64%)
AMZN   2,179.85 (+1.12%)
NVDA   312.51 (+5.37%)
MU   59.62 (+3.24%)
GE   12.76 (+0.08%)
AMD   59.09 (+3.87%)
ACB   1.70 (+3.66%)
F   8.01 (-0.62%)
NFLX   388.29 (+0.13%)
BAC   34.79 (+1.52%)
DIS   141.17 (+1.46%)
GILD   67.14 (+0.18%)
S&P 500   3,390.76 (+0.61%)
DOW   29,382.10 (+0.51%)
QQQ   237.18 (+1.04%)
FB   217.85 (+0.02%)
MSFT   187.34 (+0.06%)
GOOGL   1,529.14 (+0.64%)
AMZN   2,179.85 (+1.12%)
NVDA   312.51 (+5.37%)
MU   59.62 (+3.24%)
GE   12.76 (+0.08%)
AMD   59.09 (+3.87%)
ACB   1.70 (+3.66%)
F   8.01 (-0.62%)
NFLX   388.29 (+0.13%)
BAC   34.79 (+1.52%)
DIS   141.17 (+1.46%)
GILD   67.14 (+0.18%)
Log in

NYSE:BME - Blackrock Health Sciences Trust Stock Price, Forecast & News

$43.74
+0.09 (+0.21 %)
(As of 02/19/2020 01:45 PM ET)
Today's Range
$43.74
Now: $43.74
$43.74
50-Day Range
$41.12
MA: $42.49
$43.99
52-Week Range
$35.60
Now: $43.74
$43.99
Volume2 shs
Average Volume38,362 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BetaN/A
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Industry, Sector and Symbol

Industry Closed-End Fund - Equity
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone+1-800-8820052

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BME News and Ratings via Email

Sign-up to receive the latest news and ratings for BME and its competitors with MarketBeat's FREE daily newsletter.


Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions

What is Blackrock Health Sciences Trust's stock symbol?

Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust announced a monthly dividend on Monday, February 3rd. Stockholders of record on Friday, February 14th will be paid a dividend of $0.20 per share on Friday, February 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 5.49%. The ex-dividend date is Thursday, February 13th. View Blackrock Health Sciences Trust's Dividend History.

Has Blackrock Health Sciences Trust been receiving favorable news coverage?

Media coverage about BME stock has been trending positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Blackrock Health Sciences Trust earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Blackrock Health Sciences Trust.

Who are some of Blackrock Health Sciences Trust's key competitors?

What other stocks do shareholders of Blackrock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blackrock Health Sciences Trust investors own include Gilead Sciences (GILD), AbbVie (ABBV), AT&T (T), Verizon Communications (VZ), Enterprise Products Partners (EPD), IBM (IBM), Exxon Mobil (XOM), Alibaba Group (BABA), Blackstone Group (BX) and Energy Transfer LP Unit (ET).

Who are Blackrock Health Sciences Trust's key executives?

Blackrock Health Sciences Trust's management team includes the folowing people:
  • Mr. John M. Perlowski, Chief Exec. Officer and Pres (Age 55)
  • Mr. Neal J. Andrews, Chief Financial Officer (Age 53)
  • Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 52)
  • Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
  • Mr. Jay M. Fife, Treasurer (Age 49)

Who are Blackrock Health Sciences Trust's major shareholders?

Blackrock Health Sciences Trust's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bank of America Corp DE (0.00%), UBS Group AG (0.00%), Raymond James Financial Services Advisors Inc. (0.00%), Cambridge Investment Research Advisors Inc. (0.00%), Raymond James & Associates (0.00%) and Rikoon Group LLC (0.00%). View Institutional Ownership Trends for Blackrock Health Sciences Trust.

Which institutional investors are selling Blackrock Health Sciences Trust stock?

BME stock was sold by a variety of institutional investors in the last quarter, including Cetera Advisor Networks LLC, Advisor Group Inc. and Ladenburg Thalmann Financial Services Inc.. View Insider Buying and Selling for Blackrock Health Sciences Trust.

Which institutional investors are buying Blackrock Health Sciences Trust stock?

BME stock was bought by a variety of institutional investors in the last quarter, including Renaissance Investment Consultants Holding Company LLC, Cetera Advisors LLC, Cambridge Investment Research Advisors Inc., Bank of America Corp DE, Raymond James Financial Services Advisors Inc., Corrado Advisors LLC, Raymond James & Associates and Wealthcare Advisory Partners LLC. View Insider Buying and Selling for Blackrock Health Sciences Trust.

How do I buy shares of Blackrock Health Sciences Trust?

Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Blackrock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $43.74.

What is Blackrock Health Sciences Trust's official website?

The official website for Blackrock Health Sciences Trust is http://www2.blackrock.com/.

How can I contact Blackrock Health Sciences Trust?

Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.


MarketBeat Community Rating for Blackrock Health Sciences Trust (NYSE BME)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  142 (Vote Outperform)
Underperform Votes:  150 (Vote Underperform)
Total Votes:  292
MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Featured Article: Resistance Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel